AVE — Avecho Biotechnology Share News
0.000.00%
- AU$55.10m
- AU$50.45m
- AU$1.24m
Australia Stock Exchange release from AVECHO BIOTECHNO : AVE receives firm commitment to raise $5.06 via placement
Brief: Avecho Biotechnology Seeks Trading Halt
Australia Stock Exchange release from AVECHO BIOTECHNO : Trading Halt
Australia Stock Exchange release from AVECHO BIOTECHNO : PRE_NR Ends: 17:26:46
Australia Stock Exchange release from AVECHO BIOTECHNO : December 2020 Quarterly Activities Report & Appendix 4C
Avecho Biotechnology hits 5-yr high, begins human trial for oral canabbis formulation
Australia Stock Exchange release from AVECHO BIOTECHNO : PRE_NR Ends: 10:12:03
Australia Stock Exchange release from AVECHO BIOTECHNO : AVE begins Human Trial on CBD product
Australia Stock Exchange release from AVECHO BIOTECHNO : Section 708A Cleansing Statement & Appendix 2A
Australia Stock Exchange release from AVECHO BIOTECHNO : Grant of Unlisted Options & Appendix 3G
Avecho Biotechnology jumps after drug delivery system clears toxicology study
Australia Stock Exchange release from AVECHO BIOTECHNO : Improved Propofol TPM Formulation Passes Toxicology Study
Australia Stock Exchange release from AVECHO BIOTECHNO : PRE_NR Ends: 09:05:48
Australia Stock Exchange release from AVECHO BIOTECHNO : September 2020 Quarterly Activities Report & Appendix 4C
Australia Stock Exchange release from AVECHO BIOTECHNO : PRE_NR Ends: 13:09:20
Australia Stock Exchange release from AVECHO BIOTECHNO : PRE_NR Ends: 08:58:29
Australia Stock Exchange release from AVECHO BIOTECHNO : Response to ASX Price Query
Australia Stock Exchange release from AVECHO BIOTECHNO : PRE_NR Ends: 09:06:35
Australia Stock Exchange release from AVECHO BIOTECHNO : TPM Cannabinoid Development Program Update